A randomized, single-blind (rater)-blind, parallel-group monotherapy trial to evaluate the pharmacokinetics and safety of tralokinumab in children (2 to <12 years) with moderate to severe atopic dermatitis. TRAPEDS 1

CLINICAL TRIAL WITH MEDICINES